当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 资产负债表

金城医药

(300233)

  

流通市值:49.25亿  总市值:50.79亿
流通股本:3.72亿   总股本:3.84亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金963,334,464.55776,238,222.72825,798,100.6669,373,335
  交易性金融资产-180,000,00070,000,00072,000,000
  衍生金融资产--20,987.16-
  应收票据及应收账款457,477,427.75567,993,779.28566,278,606.95440,994,213.22
  其中:应收票据-23,910,206.4931,392,062.7121,096,392
        应收账款457,477,427.75544,083,572.79534,886,544.24419,897,821.22
  应收款项融资208,454,880.69165,655,892.1125,520,101.18139,746,625.88
  预付款项23,282,482.9328,272,985.6623,930,814.3330,309,818.64
  其他应收款合计3,886,076.193,680,311.793,472,578.544,163,622.44
  存货486,589,979.21446,540,224.09464,607,381.98528,473,986.7
  其他流动资产26,310,276.996,374,111.676,205,853.569,674,485.37
  流动资产合计2,169,335,588.312,174,755,527.312,085,834,424.31,894,736,087.25
非流动资产:
  长期股权投资18,266,325.7118,328,931.2918,400,459.418,507,694.54
  其他权益工具投资162,441,261.6163,441,261.6163,441,261.6165,266,720.59
  固定资产2,020,847,036.952,079,085,828.652,137,608,115.562,199,526,627.89
  在建工程16,466,671.448,994,262.353,362,026.3512,358,446.23
  使用权资产6,069,277.66,597,663.287,126,048.967,684,733.88
  无形资产547,178,228.31542,975,551.52545,609,701.21513,748,541.43
  开发支出94,561,206.08132,320,264.09138,861,588.64234,389,619.15
  长期待摊费用7,774,412.698,557,931.929,119,615.189,892,890.49
  递延所得税资产37,409,842.9441,866,968.9147,602,189.3650,379,968.6
  其他非流动资产28,523,284.4934,042,027.0633,926,241.5234,561,546.1
  非流动资产合计2,939,537,547.813,036,210,690.673,105,057,247.783,246,316,788.9
  资产总计5,108,873,136.125,210,966,217.985,190,891,672.085,141,052,876.15
流动负债:
  短期借款80,045,482.2370,045,130.55120,076,880.56120,066,694.45
  衍生金融负债96,260.06128,103.96-1,679.81
  应付票据及应付账款421,140,974.38469,580,668.17498,187,495.69435,064,113.2
  其中:应付票据110,812,224155,280,241.63154,154,513.42103,161,408.02
        应付账款310,328,750.38314,300,426.54344,032,982.27331,902,705.18
  预收款项100,149.89---
  合同负债37,712,662.95107,514,448.4640,779,189.0431,619,414.79
  应付职工薪酬180,328,446.88157,690,426.3185,543,719.97181,629,373.25
  应交税费27,990,583.3441,497,965.7334,569,111.0530,126,542.46
  其他应付款合计150,369,316.52159,602,373.43170,694,612.62191,727,274.3
  一年内到期的非流动负债235,555,891.14244,791,292.54170,436,860.1991,668,278.15
  其他流动负债3,371,358.334,267,695.781,801,067.262,738,168.04
  流动负债合计1,136,711,125.721,255,118,104.921,222,088,936.381,084,641,538.45
非流动负债:
  长期借款16,970,730.1417,477,78085,522,784.31163,335,174.97
  租赁负债2,386,072.44,061,461.853,400,065.085,758,667.75
  预计负债69,300--2,030,800
  递延收益40,854,700.2543,187,776.145,235,415.953,939,915.5
  递延所得税负债102,249,088.68106,803,934.12110,678,705.01113,938,137.96
  非流动负债合计162,529,891.47171,530,952.07244,836,970.3339,002,696.18
  负债合计1,299,241,017.191,426,649,056.991,466,925,906.681,423,644,234.63
所有者权益(或股东权益):
  实收资本(或股本)383,874,587383,874,587383,874,587383,874,587
  资本公积2,330,377,334.252,330,377,334.252,330,377,334.252,327,697,793.59
  减:库存股55,009,17055,009,17055,009,17055,009,170
  其他综合收益50,900,262.8751,650,262.8751,650,262.8753,319,357.11
  专项储备10,935,951.5710,453,578.769,112,422.529,561,886.91
  盈余公积165,120,502.47165,120,502.47165,120,502.47146,083,594
  未分配利润860,233,437.54836,054,180.15778,259,677.39784,687,404.82
  归属于母公司股东权益合计3,746,432,905.73,722,521,275.53,663,385,616.53,650,215,453.43
  少数股东权益63,199,213.2361,795,885.4960,580,148.967,193,188.09
  股东权益合计3,809,632,118.933,784,317,160.993,723,965,765.43,717,408,641.52
  负债和股东权益合计5,108,873,136.125,210,966,217.985,190,891,672.085,141,052,876.15
公告日期2026-08-212026-04-242026-03-272025-10-27
审计意见(境内)标准无保留意见
TOP↑